Technology News and Research

RSS

Blood transfusions based on single low hematocrit measurement questioned

A comparison study of nearly 1,900 patients published in Perfusion, a peer-reviewed academic journal, questions the long-standing practice of basing blood transfusion decisions on a single low hematocrit measurement result. In the study, titled Is it the Patient or the Physician who Cannot Tolerate Anemia?, researchers showed that a single measure of hematocrit is not a reliable indicator of transfusion need and that lower-than-normal hemoglobin levels have no adverse impact on patients.

19 Feb 2010

UCSF, Genentech partner to discover and develop drug candidates for neurodegenerative diseases

The University of California, San Francisco has signed a partnership agreement with Genentech, Inc., a wholly owned member of the Roche Group, to discover and develop drug candidates for neurodegenerative diseases.

19 Feb 2010

Johns Hopkins Kimmel Cancer Center scientists develop genome-based blood tests for cancer

Scientists at the Johns Hopkins Kimmel Cancer Center have used data from the whole genome sequencing of cancer patients to develop individualized blood tests they believe can help physicians tailor patients' treatments. The genome-based blood tests, believed to be the first of their kind, may be used to monitor tumor levels after therapy and determine cancer recurrence.

19 Feb 2010

Cellular metabolism plays a key role in cancer development

It is not unusual to hear people blame their metabolism after gaining a few pounds. But changes in metabolism - the process that shapes how our bodies turn food into energy -- can have much more sinister effects than making it hard to fit into your favorite jeans.

19 Feb 2010

The Hamner Institutes signs formal Memorandum of Understanding with Oslo Cancer Cluster

The Hamner Institutes at Research Triangle Park has signed a formal Memorandum of Understanding with the Oslo Cancer Cluster in Oslo, Norway, one of the leading cancer clusters in Europe. The goal of the collaboration is to strengthen The Hamner's Global BioScience Gateway for Translational Research and Business Development, which began with partnerships in China.

19 Feb 2010

Neuralstem raises $5.25M, also receives NYSE Amex compliance notice

Neuralstem, Inc. announced today that it has raised a total of $5,228,000 since the beginning of the year, comprised of a previously disclosed $1.5 million private placement of 646,551 common shares at $2.32, priced at a 30 percent premium over the market on the closing, and approximately $3.7 million from warrant exercises.

19 Feb 2010

Report examines how medical technology changes state of health care

Federal researchers Wednesday released a report that examines how medical technology is changing the state of health care.

19 Feb 2010

RainDance Technologies enters into strategic agreement with Applied Biosystems

RainDance Technologies, Inc., a leading provider of innovative microdroplet-based solutions for human health and disease research, and Applied Biosystems, part of Life Technologies Corporation, announced today they have entered into a strategic agreement to co-market the first solution that combines microdroplet PCR-based sequence enrichment with next-generation sequencing.

19 Feb 2010

Walker's book focuses on deaths, genetic deformities and other health issues resulting from environmental pollution

Since the brain-injuring virus needs mosquitoes and pigs to spread, government officials should ban standing water in cemetery cisterns and urban drainage ditches. They should keep industrial "piggeries" away from cities and their populations.

19 Feb 2010

Beacon Partners continues to grow to meet the needs of healthcare industry

As the healthcare community continues to ready itself to make the most of the stimulus funds in accordance with the ARRA, healthcare management consulting firm Beacon Partners’ growth pattern continues with an aggressive hiring pattern to meet the needs of the healthcare industry.

19 Feb 2010

The Methodist Hospital Research Institute awarded $11.5M NIH grant for research into methods of targeting cancer stem cells

The Methodist Hospital Research Institute was awarded an $11.5 million Center Grant by the National Institutes for Health (NIH) today to study the best way to attack deadly cancer stem cells to enhance treatments for breast cancer. Other members of the team include Baylor College of Medicine and the University of Texas Health Science Center at Houston.

19 Feb 2010

IMS Health launches IMS Aggregate Spend Compliance Services

IMS Health, the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the launch of IMS Aggregate Spend Compliance Services, a comprehensive set of solutions to help pharmaceutical and medical device companies comply with the growing number of federal and state transparency and marketing disclosure laws in the U.S., known as “aggregate spend” reporting regulations.

18 Feb 2010

Anulex Technologies announces the commercial availability of Xclose Plus Tissue Repair System

Anulex Technologies, Inc., a privately held medical device manufacturer focusing on spinal disc Preservation & Anular Repair™ products, announced the commercial availability of the Xclose™ Plus Tissue Repair System at the AANS/CNS Joint Section on Disorders of the Spine and Peripheral Nerves meeting in Orlando, Florida.

18 Feb 2010

Johns Hopkins Medicine acquires Naviscan Positron Emission Mammography for radiotracer research

Johns Hopkins Medicine has become the latest academic medical center to acquire the Naviscan Positron Emission Mammography (PEM) scanner. The device will be utilized by Richard Wahl, M.D., F.A.C.R, Professor of Radiology and Nuclear Medicine at the Johns Hopkins University School of Medicine, in pre-clinical and translational research for the development of novel radiotracers.

18 Feb 2010

AltraVax acquires vaccine development technology package from Maxygen

AltraVax, Inc., a new, privately-held biopharmaceutical company, has acquired a vaccine development technology package from Maxygen, Inc. that gives AltraVax an exclusive license to develop vaccines for infectious diseases and is targeting influenza, a treatment for hepatitis B and HIV.

18 Feb 2010

CryoLife discloses financial results for fourth-quarter and full-year 2009

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, announced today that revenues for the fourth quarter of 2009 increased 12 percent to a quarterly record of $28.6 million compared to $25.5 million for the fourth quarter of 2008. This was the 12th consecutive quarter of profitability for the Company.

18 Feb 2010

Merge Healthcare passes interoperability tests at IHE Connectathon

As a part of its ongoing commitment to interoperability standards, Merge Healthcare, a leading health IT solutions provider, announced that it successfully passed interoperability tests at the Integrating the Healthcare Enterprise (IHE), North American Connectathon event in Chicago, Illinois. During the testing, which connects vendor solutions to promote better electronic information exchange, Merge demonstrated interoperability with every vendor pairing, which included some of the largest companies in the world.

18 Feb 2010

BIOGUARD wound dressings with Quick-Med’s NIMBUS antimicrobial technology to be sold by Medline Industries

Quick-Med Technologies, Inc. announced today that its licensee, Derma Sciences, Inc., has entered into an exclusive distribution agreement with Medline Industries whereby Medline will market and sell BIOGUARD™ wound dressings with Quick-Med’s proprietary NIMBUS antimicrobial technology. The agreement covers the acute care segment of the health care market, which includes nearly 6,000 hospitals in the United States plus surgery centers, wound care centers, and other associated health care facilities. Sales under this new agreement are expected to start later this month.

18 Feb 2010

Intezyne announces new patents covering IVECT Method in major pharmaceutical markets

Intezyne today announced the issuance of new patents that cover multiple dimensions of the Company’s revolutionary technology platform, the IVECTTM Method, in the major pharmaceutical markets of the United States, Europe, and Japan. All patents are wholly owned by Intezyne.

18 Feb 2010

Emtec to demonstrate thin client solution at HIMSS 2010 Conference and Exhibition

Emtec, Inc., a systems integrator, announced today that it will demonstrate its thin client solution for healthcare in the Avnet booth #7467 at the HIMSS 2010 Conference and Exhibition. This solution integrates the ThinIdentity™ virtual desktop infrastructure solution, smart card technology and stateless thin-client computing based on the Sun Microsystems™ Sun Ray virtual display client.

18 Feb 2010

Technology News and Research

Blood transfusions based on single low hematocrit measurement questioned

UCSF, Genentech partner to discover and develop drug candidates for neurodegenerative diseases

Johns Hopkins Kimmel Cancer Center scientists develop genome-based blood tests for cancer

Cellular metabolism plays a key role in cancer development

The Hamner Institutes signs formal Memorandum of Understanding with Oslo Cancer Cluster

Neuralstem raises $5.25M, also receives NYSE Amex compliance notice

Report examines how medical technology changes state of health care

RainDance Technologies enters into strategic agreement with Applied Biosystems

Walker's book focuses on deaths, genetic deformities and other health issues resulting from environmental pollution

Beacon Partners continues to grow to meet the needs of healthcare industry

The Methodist Hospital Research Institute awarded $11.5M NIH grant for research into methods of targeting cancer stem cells

IMS Health launches IMS Aggregate Spend Compliance Services

Anulex Technologies announces the commercial availability of Xclose Plus Tissue Repair System

Johns Hopkins Medicine acquires Naviscan Positron Emission Mammography for radiotracer research

AltraVax acquires vaccine development technology package from Maxygen

CryoLife discloses financial results for fourth-quarter and full-year 2009

Merge Healthcare passes interoperability tests at IHE Connectathon

BIOGUARD wound dressings with Quick-Med’s NIMBUS antimicrobial technology to be sold by Medline Industries

Intezyne announces new patents covering IVECT Method in major pharmaceutical markets

Emtec to demonstrate thin client solution at HIMSS 2010 Conference and Exhibition

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News